197 related articles for article (PubMed ID: 26239580)
1. Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy.
Pozios I; Corona-Villalobos C; Sorensen LL; Bravo PE; Canepa M; Pisanello C; Pinheiro A; Dimaano VL; Luo H; Dardari Z; Zhou X; Kamel I; Zimmerman SL; Bluemke DA; Abraham MR; Abraham TP
Am J Cardiol; 2015 Sep; 116(6):938-44. PubMed ID: 26239580
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
[TBL] [Abstract][Full Text] [Related]
3. Rest and Stress Longitudinal Systolic Left Ventricular Mechanics in Hypertrophic Cardiomyopathy: Implications for Prognostication.
Pozios I; Pinheiro A; Corona-Villalobos C; Sorensen LL; Dardari Z; Liu HY; Cresswell K; Phillip S; Bluemke DA; Zimmerman SL; Abraham MR; Abraham TP
J Am Soc Echocardiogr; 2018 May; 31(5):578-586. PubMed ID: 29426649
[TBL] [Abstract][Full Text] [Related]
4. Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
Sorensen LL; Liang HY; Pinheiro A; Hilser A; Dimaano V; Olsen NT; Hansen TF; Sogaard P; Nowbar A; Pisanello C; Pozios I; Phillip S; Zhou X; Abraham R; Abraham TP
Am Heart J; 2017 Feb; 184():47-54. PubMed ID: 27892886
[TBL] [Abstract][Full Text] [Related]
5. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
6. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
[TBL] [Abstract][Full Text] [Related]
7. Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.
Lu DY; Yalçin H; Yalçin F; Zhao M; Sivalokanathan S; Valenta I; Tahari A; Pomper MG; Abraham TP; Schindler TH; Abraham MR
Am J Cardiol; 2018 May; 121(9):1081-1089. PubMed ID: 29678336
[TBL] [Abstract][Full Text] [Related]
8. Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy.
Kaimoto S; Kawasaki T; Kuribayashi T; Yamano M; Miki S; Kamitani T; Matsubara H
Int J Cardiovasc Imaging; 2012 Oct; 28(7):1829-39. PubMed ID: 22187199
[TBL] [Abstract][Full Text] [Related]
9. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA
Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
[TBL] [Abstract][Full Text] [Related]
11. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
[TBL] [Abstract][Full Text] [Related]
12. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
[TBL] [Abstract][Full Text] [Related]
13. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
14. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
[TBL] [Abstract][Full Text] [Related]
15. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
[TBL] [Abstract][Full Text] [Related]
16. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
Desai MY; Bhonsale A; Smedira NG; Naji P; Thamilarasan M; Lytle BW; Lever HM
Circulation; 2013 Jul; 128(3):209-16. PubMed ID: 23770748
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.
Smith BM; Dorfman AL; Yu S; Russell MW; Agarwal PP; Mahani MG; Lu JC
Am J Cardiol; 2014 Apr; 113(7):1234-9. PubMed ID: 24513464
[TBL] [Abstract][Full Text] [Related]
18. Dyssynchrony and the risk of ventricular arrhythmias.
Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
[TBL] [Abstract][Full Text] [Related]
19. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
[TBL] [Abstract][Full Text] [Related]
20. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY
Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
